Impact of body mass index and examination type on utilization of screening programs: A big data study

To investigate the relationship between Body Mass Index (BMI) and adherence to recommended screening tests, addressing gaps in previous literature by utilizing a large cohort, while considering longitudinal changes in weight and the type of screening. Data from Clalit Health Services in Israel were...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Preventive medicine Jg. 185; S. 108045
Hauptverfasser: Udi, Yarin, Gilad-Bachrach, Ran, Cohen, Hilla, Sagi-Dain, Lena
Format: Journal Article
Sprache:Englisch
Veröffentlicht: United States Elsevier Inc 01.08.2024
Schlagworte:
ISSN:0091-7435, 1096-0260, 1096-0260
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Abstract To investigate the relationship between Body Mass Index (BMI) and adherence to recommended screening tests, addressing gaps in previous literature by utilizing a large cohort, while considering longitudinal changes in weight and the type of screening. Data from Clalit Health Services in Israel were retrospectively analyzed, including participants aged 50 and above from 2002 to 2021. BMI measurements and various screening test records were examined. Generalized Estimating Equations were employed for analysis, adjusting for potential confounding variables, including age, gender, geographic location, and socioeconomic status. The study included 634,879 participants with 4,630,030 BMI measurements and 56,453,659 test records. Participants were categorized into BMI cohorts at the time of the test, with overweight and obese individuals showing lower odds of undergoing intimate examination-based screening tests (mammography, PAPS, and skin examination), as opposed to higher odds of several non-intimate tests (e.g., diabetes and eye disorder screenings). Our findings suggest that individuals with overweight and obesity are less likely to undergo screenings involving intimate physical examinations, potentially due to weight stigma and discomfort. This avoidance behavior may contribute to increased morbidity rates in these populations. Interventions addressing weight stigma, improving access to care, and enhancing patient engagement are warranted.
AbstractList To investigate the relationship between Body Mass Index (BMI) and adherence to recommended screening tests, addressing gaps in previous literature by utilizing a large cohort, while considering longitudinal changes in weight and the type of screening. Data from Clalit Health Services in Israel were retrospectively analyzed, including participants aged 50 and above from 2002 to 2021. BMI measurements and various screening test records were examined. Generalized Estimating Equations were employed for analysis, adjusting for potential confounding variables, including age, gender, geographic location, and socioeconomic status. The study included 634,879 participants with 4,630,030 BMI measurements and 56,453,659 test records. Participants were categorized into BMI cohorts at the time of the test, with overweight and obese individuals showing lower odds of undergoing intimate examination-based screening tests (mammography, PAPS, and skin examination), as opposed to higher odds of several non-intimate tests (e.g., diabetes and eye disorder screenings). Our findings suggest that individuals with overweight and obesity are less likely to undergo screenings involving intimate physical examinations, potentially due to weight stigma and discomfort. This avoidance behavior may contribute to increased morbidity rates in these populations. Interventions addressing weight stigma, improving access to care, and enhancing patient engagement are warranted.
AbstractObjectiveTo investigate the relationship between Body Mass Index (BMI) and adherence to recommended screening tests, addressing gaps in previous literature by utilizing a large cohort, while considering longitudinal changes in weight and the type of screening. MethodsData from Clalit Health Services in Israel were retrospectively analyzed, including participants aged 50 and above from 2002 to 2021. BMI measurements and various screening test records were examined. Generalized Estimating Equations were employed for analysis, adjusting for potential confounding variables, including age, gender, geographic location, and socioeconomic status. ResultsThe study included 634,879 participants with 4,630,030 BMI measurements and 56,453,659 test records. Participants were categorized into BMI cohorts at the time of the test, with overweight and obese individuals showing lower odds of undergoing intimate examination-based screening tests (mammography, PAPS, and skin examination), as opposed to higher odds of several non-intimate tests (e.g., diabetes and eye disorder screenings). DiscussionOur findings suggest that individuals with overweight and obesity are less likely to undergo screenings involving intimate physical examinations, potentially due to weight stigma and discomfort. This avoidance behavior may contribute to increased morbidity rates in these populations. Interventions addressing weight stigma, improving access to care, and enhancing patient engagement are warranted.
To investigate the relationship between Body Mass Index (BMI) and adherence to recommended screening tests, addressing gaps in previous literature by utilizing a large cohort, while considering longitudinal changes in weight and the type of screening.OBJECTIVETo investigate the relationship between Body Mass Index (BMI) and adherence to recommended screening tests, addressing gaps in previous literature by utilizing a large cohort, while considering longitudinal changes in weight and the type of screening.Data from Clalit Health Services in Israel were retrospectively analyzed, including participants aged 50 and above from 2002 to 2021. BMI measurements and various screening test records were examined. Generalized Estimating Equations were employed for analysis, adjusting for potential confounding variables, including age, gender, geographic location, and socioeconomic status.METHODSData from Clalit Health Services in Israel were retrospectively analyzed, including participants aged 50 and above from 2002 to 2021. BMI measurements and various screening test records were examined. Generalized Estimating Equations were employed for analysis, adjusting for potential confounding variables, including age, gender, geographic location, and socioeconomic status.The study included 634,879 participants with 4,630,030 BMI measurements and 56,453,659 test records. Participants were categorized into BMI cohorts at the time of the test, with overweight and obese individuals showing lower odds of undergoing intimate examination-based screening tests (mammography, PAPS, and skin examination), as opposed to higher odds of several non-intimate tests (e.g., diabetes and eye disorder screenings).RESULTSThe study included 634,879 participants with 4,630,030 BMI measurements and 56,453,659 test records. Participants were categorized into BMI cohorts at the time of the test, with overweight and obese individuals showing lower odds of undergoing intimate examination-based screening tests (mammography, PAPS, and skin examination), as opposed to higher odds of several non-intimate tests (e.g., diabetes and eye disorder screenings).Our findings suggest that individuals with overweight and obesity are less likely to undergo screenings involving intimate physical examinations, potentially due to weight stigma and discomfort. This avoidance behavior may contribute to increased morbidity rates in these populations. Interventions addressing weight stigma, improving access to care, and enhancing patient engagement are warranted.DISCUSSIONOur findings suggest that individuals with overweight and obesity are less likely to undergo screenings involving intimate physical examinations, potentially due to weight stigma and discomfort. This avoidance behavior may contribute to increased morbidity rates in these populations. Interventions addressing weight stigma, improving access to care, and enhancing patient engagement are warranted.
ArticleNumber 108045
Author Cohen, Hilla
Udi, Yarin
Gilad-Bachrach, Ran
Sagi-Dain, Lena
Author_xml – sequence: 1
  givenname: Yarin
  surname: Udi
  fullname: Udi, Yarin
  organization: Department of Biomedical Engineering, Tel-Aviv University, Tel-Aviv, Israel
– sequence: 2
  givenname: Ran
  surname: Gilad-Bachrach
  fullname: Gilad-Bachrach, Ran
  organization: Department of Biomedical Engineering, Tel-Aviv University, Tel-Aviv, Israel
– sequence: 3
  givenname: Hilla
  surname: Cohen
  fullname: Cohen, Hilla
  organization: Research Authority, Clalit Health Care Organization, Carmel Medical Center, Haifa, Israel
– sequence: 4
  givenname: Lena
  surname: Sagi-Dain
  fullname: Sagi-Dain, Lena
  email: lena.s@technion.ac.il
  organization: Genetics Institute, Obstetrics and Gynecology department, Carmel Medical Center, affiliated to the Ruth and Bruce Rappaport Faculty of Medicine, Technion - Israel Institute of Technology, Haifa, Israel
BackLink https://www.ncbi.nlm.nih.gov/pubmed/38901741$$D View this record in MEDLINE/PubMed
BookMark eNqFklFrFDEUhYNU7Lb6CwTJoy-z3puZnZkoFkqxtVDwQX0OmeTuknUmsyYZ6fjrzXarDwXZpwuX852Ec-4ZO_GjJ8ZeIywRsH63Xc67gexSgKjypoVq9YwtEGRdgKjhhC0AJBZNVa5O2VmMWwDEGqoX7LRsJWBT4YLR7bDTJvFxzbvRznzQMXLnLd1z7S2nez04r5MbPU_zjnieU3K9-33YZSyaQOSd3_BdGDdBD_E9v-Sd23Crk-YxTXZ-yZ6vdR_p1eM8Z9-vP327-lzcfbm5vbq8K0xV16kQJFadLY1eN7UULbYkEY22uGoIjdQg27LDTkpRrwUY2wpL2NWyg0Zi2VXlOXt78M1f-TlRTGpw0VDfa0_jFFUJDbRl2yJm6ZtH6dTlFNUuuEGHWf2NJgvKg8CEMcZA638SBLUvQG3VQwFqX4A6FJAp-YQyLj1klYJ2_RH244GlHNEvR0FF48gbsi6QScqO7gh_8YQ3vfPO6P4HzRS34xR8Tl-hikKB-ro_j_11iApAADTZ4MP_DY4-_weCd8pc
CitedBy_id crossref_primary_10_1001_jamanetworkopen_2025_32402
Cites_doi 10.3390/ijerph16040534
10.2337/dc23-S002
10.1016/j.metabol.2018.11.001
10.1016/j.pcad.2023.01.004
10.1186/s12885-015-1296-8
10.1200/JCO.2017.75.3442
10.1002/osp4.606
10.3748/wjg.v23.i20.3632
10.1186/s13584-022-00518-9
10.1001/archinte.164.10.1140
10.1016/j.canep.2012.02.002
10.1016/j.breast.2022.04.003
10.1038/oby.2012.50
ContentType Journal Article
Copyright 2024 Elsevier Inc.
Copyright © 2024 Elsevier Inc. All rights reserved.
Copyright_xml – notice: 2024 Elsevier Inc.
– notice: Copyright © 2024 Elsevier Inc. All rights reserved.
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7X8
DOI 10.1016/j.ypmed.2024.108045
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
MEDLINE - Academic
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
MEDLINE - Academic
DatabaseTitleList


MEDLINE
MEDLINE - Academic
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: 7X8
  name: MEDLINE - Academic
  url: https://search.proquest.com/medline
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Public Health
EISSN 1096-0260
EndPage 108045
ExternalDocumentID 38901741
10_1016_j_ypmed_2024_108045
S0091743524002007
1_s2_0_S0091743524002007
Genre Journal Article
GeographicLocations Israel
GeographicLocations_xml – name: Israel
GroupedDBID ---
--K
--M
-ET
.1-
.55
.FO
.GJ
.~1
0R~
123
1B1
1CY
1P~
1RT
1~.
1~5
29O
4.4
457
4G.
53G
5RE
5VS
7-5
71M
8P~
9JM
AABNK
AAEDT
AAEDW
AAIKJ
AAKOC
AALRI
AAOAW
AAQFI
AAQQT
AAQXK
AATTM
AAWTL
AAXKI
AAXUO
AAYWO
ABBQC
ABDPE
ABFNM
ABFRF
ABJNI
ABMAC
ABMZM
ABXDB
ACDAQ
ACGFO
ACGFS
ACIEU
ACLOT
ACRLP
ACRPL
ACVFH
ADBBV
ADCNI
ADEZE
ADFGL
ADMUD
ADNMO
ADVLN
ADXHL
AEBSH
AEFWE
AEIPS
AEKER
AENEX
AEUPX
AEVXI
AFFNX
AFJKZ
AFPUW
AFRHN
AFTJW
AFXIZ
AGHFR
AGQPQ
AGUBO
AGYEJ
AHHHB
AI2
AIEXJ
AIGII
AIIUN
AIKHN
AITUG
AJRQY
AJUYK
AKBMS
AKRWK
AKYEP
ALMA_UNASSIGNED_HOLDINGS
AMRAJ
ANKPU
ANZVX
APXCP
ASPBG
AVWKF
AXJTR
AZFZN
BKOJK
BLXMC
BNPGV
CAG
COF
CS3
DM4
DU5
EBS
EFBJH
EFKBS
EFLBG
EJD
EO8
EO9
EP2
EP3
F5P
FDB
FEDTE
FGOYB
FIRID
FNPLU
FYGXN
G-2
G-Q
GBLVA
HEA
HMK
HMO
HVGLF
HZ~
IH2
IHE
J1W
KOM
LG5
LZ2
M29
M41
MO0
N4W
N9A
O-L
O9-
OAUVE
OD~
OHT
OO0
OZT
P-8
P-9
P2P
PC.
Q38
R2-
ROL
RPZ
SAE
SCC
SDF
SDG
SDP
SES
SEW
SPCBC
SSH
SSZ
T5K
TWZ
UNMZH
VJK
WUQ
X7M
XPP
Z5R
ZGI
ZMT
ZU3
~G-
~HD
~KM
0SF
AACTN
AFCTW
AFKWA
AJOXV
AMFUW
NCXOZ
PKN
RIG
9DU
AAYXX
CITATION
AGCQF
AGRNS
CGR
CUY
CVF
ECM
EIF
NPM
7X8
ID FETCH-LOGICAL-c466t-2e25bd3caf7692818e911cad157e1c9a0983b1b9926f20cd82de1b69b07913b43
ISICitedReferencesCount 1
ISICitedReferencesURI http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=001325513200001&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
ISSN 0091-7435
1096-0260
IngestDate Thu Oct 02 06:25:43 EDT 2025
Mon Jul 21 05:33:04 EDT 2025
Tue Nov 18 21:46:58 EST 2025
Sat Nov 29 04:05:58 EST 2025
Sun Apr 06 06:53:42 EDT 2025
Tue Feb 25 20:09:53 EST 2025
Tue Oct 14 19:40:06 EDT 2025
IsPeerReviewed true
IsScholarly true
Keywords Obesity
Patient-doctor communication
Preventive medicine
Weight stigma
Cancer screening
Language English
License Copyright © 2024 Elsevier Inc. All rights reserved.
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c466t-2e25bd3caf7692818e911cad157e1c9a0983b1b9926f20cd82de1b69b07913b43
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
PMID 38901741
PQID 3070838811
PQPubID 23479
PageCount 1
ParticipantIDs proquest_miscellaneous_3070838811
pubmed_primary_38901741
crossref_primary_10_1016_j_ypmed_2024_108045
crossref_citationtrail_10_1016_j_ypmed_2024_108045
elsevier_sciencedirect_doi_10_1016_j_ypmed_2024_108045
elsevier_clinicalkeyesjournals_1_s2_0_S0091743524002007
elsevier_clinicalkey_doi_10_1016_j_ypmed_2024_108045
PublicationCentury 2000
PublicationDate 2024-08-01
PublicationDateYYYYMMDD 2024-08-01
PublicationDate_xml – month: 08
  year: 2024
  text: 2024-08-01
  day: 01
PublicationDecade 2020
PublicationPlace United States
PublicationPlace_xml – name: United States
PublicationTitle Preventive medicine
PublicationTitleAlternate Prev Med
PublicationYear 2024
Publisher Elsevier Inc
Publisher_xml – name: Elsevier Inc
References Lobstein, Powis, Brinsden, Gray, World Obesity Federation (bb0055) 2023
Ren, Chen, Qiao, Zhao (bb0085) 2022; 64
Friedman, Hemler, Rossetti, Clemow, Ferrante (bb0030) 2012; 20
Messina, Lane, Anderson (bb0065) 2012; 36
Faghy, Yates, Hills, Jayasinghe, da Luz, Arena (bb0025) 2023; 76
Israel National Health Interview Survey INHIS-3 (bb0045) 2017; 374
National Academies of Sciences E, and Medicine; Health and Medicine Division; Board on Population Health and Public Health Practice; Committee on Public Health Approaches to Reduce Vision Impairment and Promote Eye Health (bb0070) 2016; 9
McBride, Fleming, George, Steiner, MacMillan (bb0060) 2019; 16
National Cancer Institute (US) (bb0075) 2002
Wang, Arca, Sinha, Hartl, Houwing, Kothari (bb0095) 2022; 28
Clarke, Fetterman, Cheung, Wentzensen, Gage, Katki (bb0010) 2018; 36
Navarro, Nicolas, Ferrandez, Lanas (bb0080) 2017; 23
Hellmann, Njor, Lynge, von Euler-Chelpin, Olsen, Tjonneland (bb0040) 2015; 15
Graham, Hayes, Cox, Mahawar, Fox, Yemm (bb0035) 2022; 8
ElSayed, Aleppo, Aroda, Bannuru, Brown, Bruemmer (bb0020) 2023; 46
Avgerinos, Spyrou, Mantzoros, Dalamaga (bb0005) 2019; 92
Elmore, Carney, Abraham, Barlow, Egger, Fosse (bb0015) 2004; 164
Katalinic, Eisemann, Waldmann (bb0050) 2015; 112
Sagi-Dain, Echar, Paska-Davis (bb0090) 2022; 11
Graham (10.1016/j.ypmed.2024.108045_bb0035) 2022; 8
National Academies of Sciences E, and Medicine; Health and Medicine Division; Board on Population Health and Public Health Practice; Committee on Public Health Approaches to Reduce Vision Impairment and Promote Eye Health (10.1016/j.ypmed.2024.108045_bb0070) 2016; 9
Lobstein (10.1016/j.ypmed.2024.108045_bb0055) 2023
McBride (10.1016/j.ypmed.2024.108045_bb0060) 2019; 16
National Cancer Institute (US) (10.1016/j.ypmed.2024.108045_bb0075)
Ren (10.1016/j.ypmed.2024.108045_bb0085) 2022; 64
Wang (10.1016/j.ypmed.2024.108045_bb0095) 2022; 28
Friedman (10.1016/j.ypmed.2024.108045_bb0030) 2012; 20
Hellmann (10.1016/j.ypmed.2024.108045_bb0040) 2015; 15
Israel National Health Interview Survey INHIS-3 (10.1016/j.ypmed.2024.108045_bb0045) 2017; 374
Elmore (10.1016/j.ypmed.2024.108045_bb0015) 2004; 164
Messina (10.1016/j.ypmed.2024.108045_bb0065) 2012; 36
Sagi-Dain (10.1016/j.ypmed.2024.108045_bb0090) 2022; 11
ElSayed (10.1016/j.ypmed.2024.108045_bb0020) 2023; 46
Faghy (10.1016/j.ypmed.2024.108045_bb0025) 2023; 76
Katalinic (10.1016/j.ypmed.2024.108045_bb0050) 2015; 112
Avgerinos (10.1016/j.ypmed.2024.108045_bb0005) 2019; 92
Clarke (10.1016/j.ypmed.2024.108045_bb0010) 2018; 36
Navarro (10.1016/j.ypmed.2024.108045_bb0080) 2017; 23
References_xml – volume: 8
  start-page: 715
  year: 2022
  end-page: 727
  ident: bb0035
  article-title: A systematic review of obesity as a barrier to accessing cancer screening services
  publication-title: Obes. Sci. Pract.
– volume: 46
  start-page: S19
  year: 2023
  end-page: S40
  ident: bb0020
  article-title: 2. Classification and diagnosis of diabetes: standards of Care in Diabetes-2023
  publication-title: Diabetes Care
– volume: 64
  start-page: 85
  year: 2022
  end-page: 99
  ident: bb0085
  article-title: Global guidelines for breast cancer screening: a systematic review
  publication-title: Breast
– volume: 164
  start-page: 1140
  year: 2004
  end-page: 1147
  ident: bb0015
  article-title: The association between obesity and screening mammography accuracy
  publication-title: Arch. Intern. Med.
– volume: 36
  start-page: 400
  year: 2012
  end-page: 408
  ident: bb0065
  article-title: Body mass index and screening for colorectal cancer: gender and attitudinal factors
  publication-title: Cancer Epidemiol.
– volume: 20
  start-page: 1611
  year: 2012
  end-page: 1617
  ident: bb0030
  article-title: Obese women’s barriers to mammography and pap smear: the possible role of personality
  publication-title: Obesity (Silver Spring)
– volume: 11
  start-page: 5
  year: 2022
  ident: bb0090
  article-title: Experiences of weight stigmatization in the Israeli healthcare system among overweight and obese individuals
  publication-title: Isr. J. Health Policy Res.
– volume: 112
  start-page: 629
  year: 2015
  end-page: 634
  ident: bb0050
  article-title: Skin cancer screening in Germany. Documenting melanoma incidence and mortality from 2008 to 2013
  publication-title: Dtsch. Arztebl. Int.
– year: 2002
  ident: bb0075
– volume: 92
  start-page: 121
  year: 2019
  end-page: 135
  ident: bb0005
  article-title: Obesity and cancer risk: emerging biological mechanisms and perspectives
  publication-title: Metabolism
– volume: 374
  year: 2017
  ident: bb0045
  article-title: 2013-2015 – Selected Findings
– volume: 36
  start-page: 1184
  year: 2018
  end-page: 1191
  ident: bb0010
  article-title: Epidemiologic evidence that excess body weight increases risk of cervical cancer by decreased detection of precancer
  publication-title: J. Clin. Oncol.
– volume: 76
  start-page: 102
  year: 2023
  end-page: 111
  ident: bb0025
  article-title: Cardiovascular disease prevention and management in the COVID-19 era and beyond: an international perspective
  publication-title: Prog. Cardiovasc. Dis.
– volume: 15
  start-page: 294
  year: 2015
  ident: bb0040
  article-title: Body mass index and participation in organized mammographic screening: a prospective cohort study
  publication-title: BMC Cancer
– volume: 23
  start-page: 3632
  year: 2017
  end-page: 3642
  ident: bb0080
  article-title: Colorectal cancer population screening programs worldwide in 2016: an update
  publication-title: World J. Gastroenterol.
– year: 2023
  ident: bb0055
  publication-title: World Obesity Atlas
– volume: 28
  year: 2022
  ident: bb0095
  article-title: Cervical cancer screening guidelines and screening practices in 11 countries: a systematic literature review
  publication-title: Prev. Med. Rep.
– volume: 9
  year: 2016
  ident: bb0070
  publication-title: Making Eye Health a Population Health Imperative: Vision for Tomorrow
– volume: 16
  year: 2019
  ident: bb0060
  article-title: Double discourse: qualitative perspectives on breast screening participation among obese women and their health care providers
  publication-title: Int. J. Environ. Res. Public Health
– volume: 16
  issue: 4
  year: 2019
  ident: 10.1016/j.ypmed.2024.108045_bb0060
  article-title: Double discourse: qualitative perspectives on breast screening participation among obese women and their health care providers
  publication-title: Int. J. Environ. Res. Public Health
  doi: 10.3390/ijerph16040534
– volume: 9
  year: 2016
  ident: 10.1016/j.ypmed.2024.108045_bb0070
– volume: 46
  start-page: S19
  issue: Suppl. 1
  year: 2023
  ident: 10.1016/j.ypmed.2024.108045_bb0020
  article-title: 2. Classification and diagnosis of diabetes: standards of Care in Diabetes-2023
  publication-title: Diabetes Care
  doi: 10.2337/dc23-S002
– volume: 112
  start-page: 629
  issue: 38
  year: 2015
  ident: 10.1016/j.ypmed.2024.108045_bb0050
  article-title: Skin cancer screening in Germany. Documenting melanoma incidence and mortality from 2008 to 2013
  publication-title: Dtsch. Arztebl. Int.
– volume: 92
  start-page: 121
  year: 2019
  ident: 10.1016/j.ypmed.2024.108045_bb0005
  article-title: Obesity and cancer risk: emerging biological mechanisms and perspectives
  publication-title: Metabolism
  doi: 10.1016/j.metabol.2018.11.001
– ident: 10.1016/j.ypmed.2024.108045_bb0075
– volume: 76
  start-page: 102
  year: 2023
  ident: 10.1016/j.ypmed.2024.108045_bb0025
  article-title: Cardiovascular disease prevention and management in the COVID-19 era and beyond: an international perspective
  publication-title: Prog. Cardiovasc. Dis.
  doi: 10.1016/j.pcad.2023.01.004
– volume: 15
  start-page: 294
  year: 2015
  ident: 10.1016/j.ypmed.2024.108045_bb0040
  article-title: Body mass index and participation in organized mammographic screening: a prospective cohort study
  publication-title: BMC Cancer
  doi: 10.1186/s12885-015-1296-8
– volume: 36
  start-page: 1184
  issue: 12
  year: 2018
  ident: 10.1016/j.ypmed.2024.108045_bb0010
  article-title: Epidemiologic evidence that excess body weight increases risk of cervical cancer by decreased detection of precancer
  publication-title: J. Clin. Oncol.
  doi: 10.1200/JCO.2017.75.3442
– volume: 8
  start-page: 715
  issue: 6
  year: 2022
  ident: 10.1016/j.ypmed.2024.108045_bb0035
  article-title: A systematic review of obesity as a barrier to accessing cancer screening services
  publication-title: Obes. Sci. Pract.
  doi: 10.1002/osp4.606
– volume: 28
  year: 2022
  ident: 10.1016/j.ypmed.2024.108045_bb0095
  article-title: Cervical cancer screening guidelines and screening practices in 11 countries: a systematic literature review
  publication-title: Prev. Med. Rep.
– year: 2023
  ident: 10.1016/j.ypmed.2024.108045_bb0055
  publication-title: World Obesity Atlas
– volume: 23
  start-page: 3632
  issue: 20
  year: 2017
  ident: 10.1016/j.ypmed.2024.108045_bb0080
  article-title: Colorectal cancer population screening programs worldwide in 2016: an update
  publication-title: World J. Gastroenterol.
  doi: 10.3748/wjg.v23.i20.3632
– volume: 11
  start-page: 5
  issue: 1
  year: 2022
  ident: 10.1016/j.ypmed.2024.108045_bb0090
  article-title: Experiences of weight stigmatization in the Israeli healthcare system among overweight and obese individuals
  publication-title: Isr. J. Health Policy Res.
  doi: 10.1186/s13584-022-00518-9
– volume: 374
  year: 2017
  ident: 10.1016/j.ypmed.2024.108045_bb0045
– volume: 164
  start-page: 1140
  issue: 10
  year: 2004
  ident: 10.1016/j.ypmed.2024.108045_bb0015
  article-title: The association between obesity and screening mammography accuracy
  publication-title: Arch. Intern. Med.
  doi: 10.1001/archinte.164.10.1140
– volume: 36
  start-page: 400
  issue: 4
  year: 2012
  ident: 10.1016/j.ypmed.2024.108045_bb0065
  article-title: Body mass index and screening for colorectal cancer: gender and attitudinal factors
  publication-title: Cancer Epidemiol.
  doi: 10.1016/j.canep.2012.02.002
– volume: 64
  start-page: 85
  year: 2022
  ident: 10.1016/j.ypmed.2024.108045_bb0085
  article-title: Global guidelines for breast cancer screening: a systematic review
  publication-title: Breast
  doi: 10.1016/j.breast.2022.04.003
– volume: 20
  start-page: 1611
  issue: 8
  year: 2012
  ident: 10.1016/j.ypmed.2024.108045_bb0030
  article-title: Obese women’s barriers to mammography and pap smear: the possible role of personality
  publication-title: Obesity (Silver Spring)
  doi: 10.1038/oby.2012.50
SSID ssj0011604
Score 2.4497426
Snippet To investigate the relationship between Body Mass Index (BMI) and adherence to recommended screening tests, addressing gaps in previous literature by utilizing...
AbstractObjectiveTo investigate the relationship between Body Mass Index (BMI) and adherence to recommended screening tests, addressing gaps in previous...
SourceID proquest
pubmed
crossref
elsevier
SourceType Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 108045
SubjectTerms Aged
Big Data
Body Mass Index
Cancer screening
Female
Humans
Internal Medicine
Israel
Male
Mass Screening - statistics & numerical data
Middle Aged
Obesity
Obesity - diagnosis
Obesity - epidemiology
Overweight - epidemiology
Patient Acceptance of Health Care - statistics & numerical data
Patient-doctor communication
Physical Examination - statistics & numerical data
Preventive medicine
Retrospective Studies
Weight stigma
Title Impact of body mass index and examination type on utilization of screening programs: A big data study
URI https://www.clinicalkey.com/#!/content/1-s2.0-S0091743524002007
https://www.clinicalkey.es/playcontent/1-s2.0-S0091743524002007
https://dx.doi.org/10.1016/j.ypmed.2024.108045
https://www.ncbi.nlm.nih.gov/pubmed/38901741
https://www.proquest.com/docview/3070838811
Volume 185
WOSCitedRecordID wos001325513200001&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
journalDatabaseRights – providerCode: PRVESC
  databaseName: Elsevier SD Freedom Collection Journals 2021
  customDbUrl:
  eissn: 1096-0260
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0011604
  issn: 0091-7435
  databaseCode: AIEXJ
  dateStart: 20211201
  isFulltext: true
  titleUrlDefault: https://www.sciencedirect.com
  providerName: Elsevier
– providerCode: PRVESC
  databaseName: Elsevier SD Freedom Collection Journals 2021
  customDbUrl:
  eissn: 1096-0260
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0011604
  issn: 0091-7435
  databaseCode: AIEXJ
  dateStart: 20141101
  isFulltext: true
  titleUrlDefault: https://www.sciencedirect.com
  providerName: Elsevier
– providerCode: PRVESC
  databaseName: Elsevier SD Freedom Collection Journals 2021
  customDbUrl:
  eissn: 1096-0260
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0011604
  issn: 0091-7435
  databaseCode: AIEXJ
  dateStart: 20211101
  isFulltext: true
  titleUrlDefault: https://www.sciencedirect.com
  providerName: Elsevier
link http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1bb9MwFLa6DSEkhGAwKJfJSLyVTHHiXMxbgcGGxoRgk8qT5SQudCpp1XRV984P5xw7cTvKCnvgJami2HVyvpyLfc5nQl6ofhGyjPU9Dd6Ax0XIPKUgcOUsVZz7OvcjUyh8lBwfp72e-NRq_WxqYWbDpCzT-VyM_6uo4RoIG0tnryFu1ylcgN8gdDiC2OH4T4I_dHWP2ai46PwA77hjOBHNOoGeK0x-MVI3069whsEM63JMbAaKBIJbW6VukrcqW76eDb51MKF0iZK29mobHqiZXlmrPy1MusBXCMkdDN8PhqrwXqv8-0TZnag-LzDq6kUO6v2Q7ASQgiD-rbKEB0fabvndzFYE3OXKOQ0smAdeS3RZA0dLOhSzHi3F5Ip6tzMNZ3sXY3iaPex_b3H3ZTLt34ycSz1sstrOpOlEYifSdrJBtoIkEqDet7qH-70PbjWKxb5l867H3rBXmTzBlbFc5eFcFcEYT-bkLrlThyC0a6Fzj7R0uU1ufqwFt01u26lcaivU7hNtEUVHfYqIoogoahBFAVF0CVEUEUXhvIQobOYQRRtEvaJdCniiiCdq8PSAnL7bP3lz4NW7c3g5j-OpF-ggyoowV_0kFsgppsFu5qpgUaJZLpQv0jBjmRBB3A_8vEiDQrMsFpmfCBZmPNwhm-Wo1I8IRaffLzgYbSE4xrg5cp4khQo0V36RtUnQvFGZ19T1uIPKUK6RZpu8dI3Glrll_e28EZVsipLBjEqA3vpmyZ-a6arWCJVksgqkL78gehA8mLSNCwRtEruWtbdrvdi__-XzBkkSbAEu8KlSj84rifY7DdOUsTZ5aCHmHh0CEzC-nD2-3mt5Qm4tPuOnZHM6OdfPyI18Nh1Uk12ykfTS3fpz-QWbvt7C
linkProvider Elsevier
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Impact+of+body+mass+index+and+examination+type+on+utilization+of+screening+programs%3A+A+big+data+study&rft.jtitle=Preventive+medicine&rft.au=Udi%2C+Yarin&rft.au=Gilad-Bachrach%2C+Ran&rft.au=Cohen%2C+Hilla&rft.au=Sagi-Dain%2C+Lena&rft.date=2024-08-01&rft.issn=0091-7435&rft.volume=185&rft.spage=108045&rft_id=info:doi/10.1016%2Fj.ypmed.2024.108045&rft.externalDBID=n%2Fa&rft.externalDocID=10_1016_j_ypmed_2024_108045
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0091-7435&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0091-7435&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0091-7435&client=summon